Wegovy is the brand name for semaglutide, which is a type of medication known as a glucagon-like peptide-1 receptor agonist (or GLP-1 agonist medication)
For Ozempic prescribed off-label for weight management, most physicians follow the same thresholds used for other anti-obesity medications: a BMI of 30 or higher (classified as obese), or a BMI of 27 or higher with at least one weight-related comorbidity
Each has different absorption profiles and clinical applications
For example: Predicting the Strength of Bases So far, we have talked about the strength of the acid
Mounjaro KwikPen 2.5mg solution for injection in pre-filled pen (2025) EMC [accessed 08 November 2025] Ozempic 0.25 mg solution for injection in pre-filled pen (2025) EMC [accessed 08 November 2025] Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen (2025) EMC [accessed 08 November 2025] GLP-1 medicines for weight loss and diabetes: what you need to know (2025) MHRA [accessed 08 November 2025] Lose weight (2025) NHS [accessed 08 November 2025] Obesity (2023) NHS [accessed 08 November 2025] Physical activity guidelines for adults aged 19 to 64 (2024) NHS [accessed 08 November 2025] Weight management injections (2025) NHS [accessed 08 November 2025] Tirzepatide for managing overweight and obesity (2025) NICE [accessed 08 November 2025] Its natural to have questions, and were here to keep things straightforward so you can stay focused on your journey
They should strictly be prescription-based, and only doctors specialised in this area of treatment should be allowed to prescribe these drugs, to cut down on the misuse or abuse of these drugs
